This Article Full Text Full Text (PDF) All Versions of this Article: 200210-1154OCv1 169/8/903    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Blanchet, M.-R. Articles by Cormier, Y. Search for Related Content PubMed PubMed Citation Articles by Blanchet, M.-R. Articles by Cormier, Y.

Inhibitory Effect of Nicotine on Experimental Hypersensitivity Pneumonitis In Vivo and In Vitro

Unité de Recherche, Centre de Pneumologie, Institut Universitaire de Cardiologie et de Pneumologie de l'Université Laval, Hôpital Laval, Quebec City, Québec, Canada

Correspondence and requests for reprints should be addressed to Yvon Cormier, M.D., Hôpital Laval, 2725 Chemin Ste-Foy, Quebec City, PQ, G1V 4G5 Canada. E-mail: yvon.cormier{at}med.ulaval.ca

The incidence of hypersensitivity pneumonitis (HP) is lower in smokers than in nonsmokers. Because nicotine is immunosuppressive, we hypothesized that it could have a protective effect on HP induction in vivo. HP was induced in mice that were treated with nicotine either intraperitoneally (IP) (0.5 to 2.0 mg/kg/day) or intranasally (IN) (0.025 to 2.0 mg/kg/day). Both IP- and IN-treated animals had fewer bronchoalveolar lavage total cells and lymphocytes and a decreased lung tissue inflammation. IFN- but not interleukin-10 mRNA expression was reduced in lung tissue of 2.0-mg/kg IN-treated animals. To test the effect of nicotine on alveolar macrophages, AMJ2-C11 cells were treated with nicotine and stimulated with lipopolysaccharide or Saccharopolyspora rectivirgula, a causative agent of HP. Nicotine reduced tumor necrosis factor release and tumor necrosis factor, interleukin-10, and IFN- mRNA expression after stimulation and decreased CD80 expression by 55% in lipopolysaccharide-stimulated cells and by 41% in S. rectivirgula–stimulated cells. We conclude that nicotine could be, at least in part, responsible for the protection observed in smokers against HP. The inhibitory effect of nicotine on alveolar macrophages could be one of the mechanisms involved.

Key Words: alveolar macrophages • nicotine • hypersensitivity pneumonitis • cytokines

This article has been cited by other articles:

				J. A Hoppin, D. M Umbach, G. J Kullman, P. K Henneberger, S. J London, M. C R Alavanja, and D. P Sandler Pesticides and other agricultural factors associated with self-reported farmer's lung among farm residents in the Agricultural Health Study Occup. Environ. Med., May 1, 2007; 64(5): 334 - 341. [Abstract] [Full Text] [PDF]

				M.-R. Blanchet, A. Langlois, E. Israel-Assayag, M.-J. Beaulieu, C. Ferland, M. Laviolette, and Y. Cormier Modulation of eosinophil activation in vitro by a nicotinic receptor agonist J. Leukoc. Biol., May 1, 2007; 81(5): 1245 - 1251. [Abstract] [Full Text] [PDF]

				I. Cloez-Tayarani and J.-P. Changeux Nicotine and serotonin in immune regulation and inflammatory processes: a perspective J. Leukoc. Biol., March 1, 2007; 81(3): 599 - 606. [Abstract] [Full Text] [PDF]

				M.-R. Blanchet, E. Israel-Assayag, P. Daleau, M.-J. Beaulieu, and Y. Cormier Dimethyphenylpiperazinium, a nicotinic receptor agonist, downregulates inflammation in monocytes/macrophages through PI3K and PLC chronic activation Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L757 - L763. [Abstract] [Full Text] [PDF]

				C. S. Robbins, M. A. Pouladi, R. Fattouh, D. E. Dawe, N. Vujicic, C. D. Richards, M. Jordana, M. D. Inman, and M. R. Stampfli Mainstream Cigarette Smoke Exposure Attenuates Airway Immune Inflammatory Responses to Surrogate and Common Environmental Allergens in Mice, Despite Evidence of Increased Systemic Sensitization J. Immunol., September 1, 2005; 175(5): 2834 - 2842. [Abstract] [Full Text] [PDF]

				M-R. Blanchet, E. Israel-Assayag, and Y. Cormier Modulation of airway inflammation and resistance in mice by a nicotinic receptor agonist Eur. Respir. J., July 1, 2005; 26(1): 21 - 27. [Abstract] [Full Text] [PDF]

				T. D. Bradley, Y. E. Miller, F. J. Martinez, D. C. Angus, W. MacNee, and E. Abraham Interstitial Lung Disease, Lung Cancer, Lung Transplantation, Pulmonary Vascular Disorders, and Sleep-disordered Breathing in AJRCCM in 2004 Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 675 - 685. [Full Text] [PDF]

				J. N. Fink, H. G. Ortega, H. Y. Reynolds, Y. F. Cormier, L. L. Fan, T. J. Franks, K. Kreiss, S. Kunkel, D. Lynch, S. Quirce, et al. Needs and Opportunities for Research in Hypersensitivity Pneumonitis Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 792 - 798. [Abstract] [Full Text] [PDF]

				D. van Westerloo, T. van der Poll, R. B. Felder, R. M. Weiss, Z.-H. Zhang, and J. Francis Acute Vagotomy Activates the Cholinergic Anti-Inflammatory Pathway Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H977 - H979. [Abstract] [Full Text] [PDF]

				A. F. Shorr, S. L. Scoville, S. B. Cersovsky, G. D. Shanks, C. F. Ockenhouse, B. L. Smoak, W. W. Carr, and B. P. Petruccelli Acute Eosinophilic Pneumonia Among US Military Personnel Deployed in or Near Iraq JAMA, December 22, 2004; 292(24): 2997 - 3005. [Abstract] [Full Text] [PDF]

				L. S. Newman, C. S. Rose, E. A. Bresnitz, M. D. Rossman, J. Barnard, M. Frederick, M. L. Terrin, S. E. Weinberger, D. R. Moller, G. McLennan, et al. A Case Control Etiologic Study of Sarcoidosis: Environmental and Occupational Risk Factors Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1324 - 1330. [Abstract] [Full Text] [PDF]

				K. Dheda, M. A. Johnson, A. Zumla, and G. A. Rook Smoking is Not Beneficial for Tuberculosis Am. J. Respir. Crit. Care Med., October 1, 2004; 170(7): 821 - 821. [Full Text] [PDF]

				D. K. C. Lee, M.-R. Blanchet, E. Israel-Assayag, Y. Cormier, and L. A. Maier Nicotine and Hypersensitivity Pneumonitis Am. J. Respir. Crit. Care Med., July 15, 2004; 170(2): 199 - 200. [Full Text]

				L. A. Maier Is Smoking Beneficial for Granulomatous Lung Diseases? Am. J. Respir. Crit. Care Med., April 15, 2004; 169(8): 893 - 895. [Full Text] [PDF]